Enhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers

Seiichiro Fukuhara, Hidekazu Suzuki, Tatsuhiro Masaoka, Mamoru Arakawa, Hiroshi Hosoda, Yuriko Minegishi, Kenji Kangawa, Hiromasa Ishii, Masaki Kitajima, Toshifumi Hibi

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Ghrelin, produced and secreted by the A-like cells of the stomach, stimulates growth hormone secretion, gastric motility, and food intake. Cysteamine inhibits the release of somatostatin and induces the formation of duodenal ulcers in rats. The present study was conducted to investigate the dynamics of ghrelin secretion in rats treated with cysteamine. Male Wistar rats (7 wk old) were administered three doses of cysteamine (400 mg/kg) orally; at 50 h after the first dose, duodenal ulcers were induced, and the plasma level of somatostatin and gastric density of somatostatin-immunoreactive cells were significantly reduced. The plasma total and active ghrelin levels were significantly higher in the cysteamine-treated rats than in the control rats, whereas the gastric ghrelin levels, number of gastric ghrelin-immunoreactive cells, and preproghrelin mRNA expression levels were significantly lower. Even at the time points of 2 and 10 h after the first dose of cysteamine, at which time no significant ulcer formation or antral neutrophil accumulation was yet noted, a significant increase in the plasma ghrelin level and decrease in the gastric ghrelin level were observed. Furthermore, although lansoprazole treatment attenuated the duodenal ulceration induced by cysteamine, the increase in the plasma level of ghrelin could still be demonstrated. Because an inverse correlation was found between the plasma ghrelin and somatostatin levels, the inhibition of somatostatin secretion may be associated with the increased ghrelin secretion. In conclusion, an increase in the plasma ghrelin level precedes the formation of duodenal ulcers in rats treated with cysteamine.

Original languageEnglish
JournalAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Volume289
Issue number1 52-1
DOIs
Publication statusPublished - 2005 Jul

Fingerprint

Cysteamine
Ghrelin
Duodenal Ulcer
Stomach
Somatostatin
Lansoprazole
Somatostatin-Secreting Cells
Growth Hormone
Ulcer
Wistar Rats
Neutrophils
Eating

Keywords

  • Somatostatin

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology

Cite this

Enhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers. / Fukuhara, Seiichiro; Suzuki, Hidekazu; Masaoka, Tatsuhiro; Arakawa, Mamoru; Hosoda, Hiroshi; Minegishi, Yuriko; Kangawa, Kenji; Ishii, Hiromasa; Kitajima, Masaki; Hibi, Toshifumi.

In: American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 289, No. 1 52-1, 07.2005.

Research output: Contribution to journalArticle

Fukuhara, Seiichiro ; Suzuki, Hidekazu ; Masaoka, Tatsuhiro ; Arakawa, Mamoru ; Hosoda, Hiroshi ; Minegishi, Yuriko ; Kangawa, Kenji ; Ishii, Hiromasa ; Kitajima, Masaki ; Hibi, Toshifumi. / Enhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers. In: American Journal of Physiology - Gastrointestinal and Liver Physiology. 2005 ; Vol. 289, No. 1 52-1.
@article{48fa45c037014aa89b9da6c89a6b3a95,
title = "Enhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers",
abstract = "Ghrelin, produced and secreted by the A-like cells of the stomach, stimulates growth hormone secretion, gastric motility, and food intake. Cysteamine inhibits the release of somatostatin and induces the formation of duodenal ulcers in rats. The present study was conducted to investigate the dynamics of ghrelin secretion in rats treated with cysteamine. Male Wistar rats (7 wk old) were administered three doses of cysteamine (400 mg/kg) orally; at 50 h after the first dose, duodenal ulcers were induced, and the plasma level of somatostatin and gastric density of somatostatin-immunoreactive cells were significantly reduced. The plasma total and active ghrelin levels were significantly higher in the cysteamine-treated rats than in the control rats, whereas the gastric ghrelin levels, number of gastric ghrelin-immunoreactive cells, and preproghrelin mRNA expression levels were significantly lower. Even at the time points of 2 and 10 h after the first dose of cysteamine, at which time no significant ulcer formation or antral neutrophil accumulation was yet noted, a significant increase in the plasma ghrelin level and decrease in the gastric ghrelin level were observed. Furthermore, although lansoprazole treatment attenuated the duodenal ulceration induced by cysteamine, the increase in the plasma level of ghrelin could still be demonstrated. Because an inverse correlation was found between the plasma ghrelin and somatostatin levels, the inhibition of somatostatin secretion may be associated with the increased ghrelin secretion. In conclusion, an increase in the plasma ghrelin level precedes the formation of duodenal ulcers in rats treated with cysteamine.",
keywords = "Somatostatin",
author = "Seiichiro Fukuhara and Hidekazu Suzuki and Tatsuhiro Masaoka and Mamoru Arakawa and Hiroshi Hosoda and Yuriko Minegishi and Kenji Kangawa and Hiromasa Ishii and Masaki Kitajima and Toshifumi Hibi",
year = "2005",
month = "7",
doi = "10.1152/ajpgi.00298.2004",
language = "English",
volume = "289",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "1 52-1",

}

TY - JOUR

T1 - Enhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers

AU - Fukuhara, Seiichiro

AU - Suzuki, Hidekazu

AU - Masaoka, Tatsuhiro

AU - Arakawa, Mamoru

AU - Hosoda, Hiroshi

AU - Minegishi, Yuriko

AU - Kangawa, Kenji

AU - Ishii, Hiromasa

AU - Kitajima, Masaki

AU - Hibi, Toshifumi

PY - 2005/7

Y1 - 2005/7

N2 - Ghrelin, produced and secreted by the A-like cells of the stomach, stimulates growth hormone secretion, gastric motility, and food intake. Cysteamine inhibits the release of somatostatin and induces the formation of duodenal ulcers in rats. The present study was conducted to investigate the dynamics of ghrelin secretion in rats treated with cysteamine. Male Wistar rats (7 wk old) were administered three doses of cysteamine (400 mg/kg) orally; at 50 h after the first dose, duodenal ulcers were induced, and the plasma level of somatostatin and gastric density of somatostatin-immunoreactive cells were significantly reduced. The plasma total and active ghrelin levels were significantly higher in the cysteamine-treated rats than in the control rats, whereas the gastric ghrelin levels, number of gastric ghrelin-immunoreactive cells, and preproghrelin mRNA expression levels were significantly lower. Even at the time points of 2 and 10 h after the first dose of cysteamine, at which time no significant ulcer formation or antral neutrophil accumulation was yet noted, a significant increase in the plasma ghrelin level and decrease in the gastric ghrelin level were observed. Furthermore, although lansoprazole treatment attenuated the duodenal ulceration induced by cysteamine, the increase in the plasma level of ghrelin could still be demonstrated. Because an inverse correlation was found between the plasma ghrelin and somatostatin levels, the inhibition of somatostatin secretion may be associated with the increased ghrelin secretion. In conclusion, an increase in the plasma ghrelin level precedes the formation of duodenal ulcers in rats treated with cysteamine.

AB - Ghrelin, produced and secreted by the A-like cells of the stomach, stimulates growth hormone secretion, gastric motility, and food intake. Cysteamine inhibits the release of somatostatin and induces the formation of duodenal ulcers in rats. The present study was conducted to investigate the dynamics of ghrelin secretion in rats treated with cysteamine. Male Wistar rats (7 wk old) were administered three doses of cysteamine (400 mg/kg) orally; at 50 h after the first dose, duodenal ulcers were induced, and the plasma level of somatostatin and gastric density of somatostatin-immunoreactive cells were significantly reduced. The plasma total and active ghrelin levels were significantly higher in the cysteamine-treated rats than in the control rats, whereas the gastric ghrelin levels, number of gastric ghrelin-immunoreactive cells, and preproghrelin mRNA expression levels were significantly lower. Even at the time points of 2 and 10 h after the first dose of cysteamine, at which time no significant ulcer formation or antral neutrophil accumulation was yet noted, a significant increase in the plasma ghrelin level and decrease in the gastric ghrelin level were observed. Furthermore, although lansoprazole treatment attenuated the duodenal ulceration induced by cysteamine, the increase in the plasma level of ghrelin could still be demonstrated. Because an inverse correlation was found between the plasma ghrelin and somatostatin levels, the inhibition of somatostatin secretion may be associated with the increased ghrelin secretion. In conclusion, an increase in the plasma ghrelin level precedes the formation of duodenal ulcers in rats treated with cysteamine.

KW - Somatostatin

UR - http://www.scopus.com/inward/record.url?scp=21744445216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21744445216&partnerID=8YFLogxK

U2 - 10.1152/ajpgi.00298.2004

DO - 10.1152/ajpgi.00298.2004

M3 - Article

VL - 289

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 1 52-1

ER -